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SIR,—An infectious ætiology for multiple sclerosis (MS) has been postulated but none of the agents putatively 




 isolation of an infectious 
agent from bone-marrow aspiration of patients with MS prompted us to attempt recovery of an agent from our 
MS patients. 
We studied samples of bone-marrow from 2 male and 5 female MS patients all meeting the accepted criteria for 
the diagnosis, and five volunteer controls (2 men, 3 women, 2 normal, 2 with seizure disorder, and 1 with an 
emotional problem) kindly obtained with permission of Dr K. Engel and Dr R. Porter of the N.I.H. 
Bone-marrow was aspirated into 10 ml Eagle's minimal essential medium (EMEM) containing preservative-free 
heparin. After washing, the samples were divided into four parts; A for tube cultures,. B for   coverslip   cultures   
in   multidish  wells; C was placed on a 'Ficoll'-'Hypaque' gradient to obtain free mononuclear cells, and D was 
frozen in liquid nitrogen in cryopreservative medium containing 1% dimethyl sulphoxide. 






1(22) RR P N 
2(32) RR D + 
3(32) RR P + 
4(24) RR D + 
5(34) RR P ± 
6(39) RR D + 
7(29) C D + 
* RR=recurrent and remitting, C=chronic; P=probably MS, D=Definite MS  
**N=normal, +=elevated IgG and oligoclonal bands, ±=borderline elevated IgG and oligoclonal bands. 
After separation of the mononuclear cells, half of sample C was incubated with 1 µg of phytohaemagglutinin for 
72 h to obtain mitogen-activated lymphocytes (C'). 0-2 ml samples from A were placed in triplicate in tube 
cultures. Six replicate multidish plate wells containing cells grown on coverslips were seeded with 0-2 ml 
aliquots of test cells from groups B, C, and C'. The cell lines employed to rescue the agent included Flow 7000 (a 
diploid human fibroblast cell line), HEP-2 (transformed human epithelial cells), Vero cells (transformed African 
green monkey kidney cells), PRK (primary rabbit kidney cells), and three separate lines of Hela cells (a 
transformed human cervical carcinoma cell line). These were grown initially in EMEM supplemented with 10% 
fetal bovine serum (FBS) and 1% L-glutamine (200 mmol/1). Bone-marrow samples were incubated on the 
monolayer cells for 2 h. The cultures were then fed with a maintenance medium (EMEM with 2% FBS) and 
were observed intermittently for two weeks. Fluid containing cells was blindly passaged twice to new tube or 
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coverslip cultures containing the corresponding monolayer cells. Each culture was maintained for six to eight 
weeks before termination. Any cultures showing cytotoxic or cytopathic effects were scraped and transferred to 
large flasks (150 cm
2
) containing freshly planted corresponding monolayer cells. These flask cultures were 
maintained for two additional weeks and then blindly passaged twice. For ultrastructural studies, the cells grown 
in large flasks were scraped off, centrifuged, and fixed in 4% cacodylate-buffered glutar-aldehyde. After 120 
min, the cells were postfixed in 1% osmium tetrox-ide, dehydrated with ethanol and embedded. Thin sections 
were then prepared for electronmicroscopic examination. 
No infectious agent was recovered from the bone-marrow samples from either the MS patients or the controls. 
Samples inoculated directly into tube and coverslip cultures of Vero, Flow 7000, PRK, and HEP-2 showed no 
cytopathic effect. However, Hela cells inoculated with samples from six of seven MS patients and three of the 
five controls rapidly formed syncytia within 24 to 48 h which frequently contained up to 25 nuclei. This 
happened to two of the three Hela cell lines. Careful re-examination of the three Hela cell lines revealed an 
occasional syncytium with 3-8 nuclei in the control cultures of two of these cell lines. When fluid and cells from 
the cultures (showing syncytial formation) with the MS patients and controls were passaged to the Hela cell line 
not forming spontaneous syncytia, occasional syncytia formed for a short period of time. In each case, the 
capacity to form syncytia could be passaged. Ultrastructural examination of cultures with syncytium revealed 
small, spiked, viral-like particles in the Hela cells resembling a foamy virus. No attempt was made to identify 
this agent further because extensive EM examination of original uninfected cultures revealed a similar type of 
agent. The passage of fluid from uninoculated control cells spontaneously showing syncytial formation did not 
enhance this effect in fresh cultures in contrast to the passage from bone-marrow cultures. Direct inoculation of 
bone-marrow cells from MS or controls on to the third Hela cell line did not result in syncytial formation. 
Therefore, we believe that a cell-associated syncytial forming agent pre-existed in two of the Hela cell lines and 
was activated when these cells were cultured with bone-marrow cells from some of the patients or controls. 
Mononuclear cells separated from bone-marrow samples by ficoll-hypaque density gradient centrifugation with 
or without phytohEemagglutinin treatment were seeded at 1x10
6
 cells/0-2 ml on to wells of the indicator cell 
lines in triplicate. Syncytial formation with Hela cells similar to that observed after direct inoculation of bone-
marrow was seen but was less frequent. In addition, samples from two of the six MS patients cultured in Vero 
cells resulted in the formation of small syncytia containing 8-12 nuclei. However, in neither case could transfer 
of fluid or cells from the affected cultures reproduce this activity nor was any activity noted from any of 
the,controls. 
In the previous investigation reporting the isolation of an infectious agent from MS bone-marrow, the agent(s) 
could be readily isolated from MS patients (5 of 5) but not from controls (0 of 7).
5
 Successful isolation was 
obtained employing MRC-S (human diploid cells), HEP-2, and Vero cells. Lysole-cithin was found to enhance 
the recovery rate of the agent(s), although it was apparently not necessary for primary isolation. We were unable 
to isolate an agent from seven MS patients with similar cell lines and procedures. There is no apparent reason for 
our inability to do so. However, we did find an adventitious agent(s) in two commercial sources of Hela cells. 
Although not initially apparent, this agent(s) became active upon incubation with either MS-patient or control 
bone-marrow cells and induced large syncytia when passed to other Hela cells. 
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